High performing experienced leader with 30 years in research, 18 years in product development, and a proven track record in the medical device/IVD industry. Specializes in driving business strategy, product life cycle management, and development for clinical, food, veterinary, and pharmaceutical markets. Successfully launched 25-30 new products, demonstrating expertise in strategic planning, market analysis, product risk/benefit assessment, and cross-functional team leadership. Expertise in regulatory compliance, business development, IP management, and driving operational efficiency. Thirty plus publications, 5 awarded patents.
Overview
20
20
years of professional experience
Work History
Corporate Vice President, R&D, Manufacturing Business Unit
Charles River Laboratories
01.2024 - Current
Refining business strategy and portfolio of Manufacturing unit for synergies, better organization, and reduction of redundancies for effective and streamlined business
Managing a $20-25M R&D budget for a $400M business, improving product portfolio and driving $34M in projected growth in 3 years for new technologies through strategic product launches and improvements
Consolidated global labs for improving efficiency and cost-effectiveness resulting in 15% impact to the bottom line
Reports to GM of Manufacturing Business unit, got promoted to include Biologics (testing), CDMO in addition to Microbial Solutions
Vice President, R&D, Microbial Solutions
Charles River Laboratories
01.2021 - 12.2023
Led the transformation of R&D and built a 92-member R&D and technical operations team across assay development, software/hardware engineering, and machine learning for microbial solutions
Directed strategy and portfolio for Microbial Solutions, launched 10 products and services, and optimized operations to gain efficiency for Endosafe, Celsis and Accugenix products and services
Implemented a structured Stage gate process to improve return on R&D investment, created project management team that enhanced completion rate of projects for 80% efficiency
Significant improvement of existing products for better customer experience to expand the business in EMEA, APAC and US
Reported to GM of Microbial business unit at executive position to transform R&D and fuel innovation
Senior Vice President / Head of R&D
Accelerate Diagnostics
01.2020 - 01.2021
Led R&D (60+ members) for the Pheno rapid ID/AST platform, expanding the menu and driving next-generation platform development
Collaborated closely with executive teams on business strategies and investor presentations
Reported to CEO and transitioned due to pandemic and personal reasons
Senior Director, R&D Microbiology US
bioMérieux Inc.
05.2006 - 12.2019
Managed R&D teams (55+ members), driving the development of clinical, veterinary, and pharmaceutical applications for BACT/ALERT, VITEK 2 and VITEK MS, including regulatory submissions and clinical trials
Led the innovation, launched 20 key IVD products in global market, ensuring patient safety and product efficacy for clinical, food, veterinary and pharma markets
Excellent understanding of FDA, ISO, GCP, ICH, CLSI, EUCAST, cGMP guidelines for medical device/IVD clearance
Representation of company at various conferences globally to promote products and services
Reported to Microbiology Business head and transitioned out for growth opportunities
Scientist, Drug Discovery
Southern Research Institute
07.2005 - 05.2006
Conducted cellular assays for vaccine development and contributed to groundbreaking tuberculosis research
Transitioned from nonprofit academia to industry
Education
MBA - Innovation and Marketing Management
NC State University
Raleigh, NC
01.2011
Ph. D - Microbiology
Post-Graduate Institute of Medical Education and Research
India
01.1997
Post graduate diploma - Biotechnology
Punjab University
India
01.1992
M.Sc. - Microbiology
Guru Nanak Dev University
India
01.1991
B.Sc. - Biology
Punjab University
India
01.1989
Affiliations
American Society of Microbiology (ASM)
European Society of Clinical Microbiology and Infectious Disease (ESCMID)
Parenteral Drug Association (PDA)
Additional Qualifications
BSL-3 Training, CDC and FBI clearance to work on select agents.
GMP and cGMP
Antimicrobial agents and chemotherapy mini course 2017, Creighton University
Global business leadership training
Project Management training
Certificate course in animal handling, research methodology and biostatistics.
Knowledge of bioinformatics software, Microsoft Office, Adobe Photoshop, Minitab, SAS, Smartsheet, Miro.
Timeline
Corporate Vice President, R&D, Manufacturing Business Unit
Charles River Laboratories
01.2024 - Current
Vice President, R&D, Microbial Solutions
Charles River Laboratories
01.2021 - 12.2023
Senior Vice President / Head of R&D
Accelerate Diagnostics
01.2020 - 01.2021
Senior Director, R&D Microbiology US
bioMérieux Inc.
05.2006 - 12.2019
Scientist, Drug Discovery
Southern Research Institute
07.2005 - 05.2006
MBA - Innovation and Marketing Management
NC State University
Ph. D - Microbiology
Post-Graduate Institute of Medical Education and Research